Get key Q3 2025 earnings call insights on Cytosorbents (CTSO): growth drivers, FDA progress, cost controls, and outlook.
11h
Xos Extends Profitability Streak with Strong Q3 2025 Performance and Positive Operating Cash Flow
Delivered 130 units and generated $16.5 million in revenueAchieved 15.3% Gross Margin and a second consecutive quarter of positive free cash flow ...
LandBridge is emerging as a royalty landlord in the heart of the Permian water bottleneck, with a fee-based model that ...
bne IntelliNews on MSN
US supermajor Chevron outlines focus on cash flow growth
By bne IntelliNews US-based supermajor Chevron unveiled its plans for the next five years at its investor day on November 12.
OilPrice.com on MSN
Chevron Targets Double-Digit Cash Flow Growth in 2030 Roadmap
Chevron (NYSE: CVX) used its investor day in New York to signal a confident long-term outlook, unveiling a five-year plan ...
Chevron said on Wednesday that it plans to grow free cash flow by more than 10% annually through 2030 and increase oil and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback